Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Magnetic Beads - Global Strategic Business Report: Capitalize on the Surge from $3.3 Billion in 2025 to $7.4 Billion by 2032 as Thermo Fisher Scientific, Merck KGaA, QIAGEN, Bio-Rad Laboratories and Miltenyi Biotec Battle for Leadership

globenewswire.com

Magnetic Beads - Global Strategic Business Report: Capitalize on the Surge from $3.3 Billion in 2025 to $7.4 Billion by 2032 as Thermo Fisher Scientific, Merck KGaA, QIAGEN, Bio-Rad Laboratories and Miltenyi Biotec Battle for Leadership Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Magnetic Beads - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

The global magnetic beads market was valued at an estimated US$3.3 billion in 2025 and is projected to reach US$7.4 billion by 2032, advancing at a compound annual growth rate (CAGR) of 12.2%. Market expansion is being supported by rising demand across biotechnology, healthcare, pharmaceutical research, molecular diagnostics, and industrial applications.

Global Magnetic Beads Market Trends and Growth Drivers

Magnetic beads are increasingly used to separate, purify, and manipulate biomolecules, cells, and pathogens. Their expanding role in genomics, proteomics, protein purification, immunoassays, molecular diagnostics, and targeted drug delivery is strengthening demand from research laboratories, diagnostic providers, and biopharmaceutical companies.

Adoption is also accelerating in point-of-care testing, infectious disease diagnostics, cancer research, regenerative medicine, and magnetic-activated cell sorting. The growing emphasis on laboratory automation, high-throughput screening, precision medicine, and personalized healthcare is further integrating magnetic bead technologies into clinical and research workflows.

Technology Innovation and Emerging Applications

Advances in nanotechnology, surface chemistry, and bead functionalization are improving binding affinity, selectivity, sensitivity, and purification efficiency. Magnetic beads featuring silica, polystyrene, and biomolecule-based coatings are enabling more precise capture of target molecules across diagnostic and research applications.

Superparamagnetic bead technologies are also improving bioassay sensitivity and compatibility with automated and microfluidic platforms. At the same time, artificial intelligence and laboratory automation are supporting faster, more consistent magnetic bead-based separation processes. Research into magnetic nanocarriers for targeted therapeutics is expected to create additional opportunities in drug delivery, nanomedicine, and advanced clinical applications.

Market Drivers, Challenges, and Opportunities

Key magnetic beads market drivers include the increasing prevalence of infectious and chronic diseases, growth in biopharmaceutical research, expansion of automated diagnostic platforms, and rising investment in precision medicine. Demand for rapid, sensitive, and scalable testing methods is encouraging broader deployment of magnetic bead-based assays.

Market challenges include relatively high manufacturing costs, stability limitations under certain operating conditions, and scalability constraints for specialized applications. However, advances in cost-efficient production, standardized manufacturing, AI-enabled workflows, and automated laboratory systems are expected to reduce barriers to adoption. Emerging uses in regenerative medicine, targeted therapy, and theranostics provide further long-term growth potential.

Report Scope and Market Segmentation

The report analyzes the global magnetic beads market by value in US dollars, covering the following verticals:

The bioresearch segment is forecast to reach US$4.8 billion by 2032, growing at a CAGR of 13.1%. The in-vitro diagnostics segment is projected to expand at a CAGR of 11.0% during the analysis period.

Geographic coverage includes the United States, Canada, Japan, China, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. The U.S. magnetic beads market was valued at approximately US$1.0 billion in 2025. China is forecast to record a CAGR of 16.6% and reach US$1.9 billion by 2032. The report also evaluates market developments in Germany, France, the United Kingdom, India, South Korea, Australia, Brazil, Mexico, Saudi Arabia, the United Arab Emirates, and other significant national markets.

Key Report Benefits

Key Questions Addressed

Companies Featured in the Magnetic Beads Market Report

Featured companies include Agilent Technologies, Inc.; Bangs Laboratories, Inc.; Bioclone Inc.; Bio-Rad Laboratories, Inc.; Cube Biotech GmbH; Diagenode S.A.; GenScript Biotech Corporation; JSR Life Sciences; Magnostics; Merck KGaA; Micromod Partikeltechnologie GmbH; Miltenyi Biotec; Omega Bio-Tek, Inc.; Promega Corporation; QIAGEN N.V.; Rockland Immunochemicals, Inc.; Spherotech, Inc.; StemCell Technologies Inc.; Takara Bio Inc.; and Thermo Fisher Scientific Inc.

Domain Expert Insights

This magnetic beads market report incorporates perspectives from domain experts across enterprise, industry, academia, and government. Insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to deliver comprehensive market intelligence and strategic analysis. As part of the research study, the report tracks and analyzes insights from 43 domain experts. Clients may request access to the expert network monitored for the report, together with the online expert insights tracker.

Key Attributes:

For more information about this report visit https://www.researchandmarkets.com/r/wfihna

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.